Adoptive transfer of ex vivo immune-programmed NKT lymphocytes alleviates immune-mediated colitis
Authors:
Open Access
- 13 October 2003
- journal article
- pathophysiology
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 75 (1) , 76-86
Abstract
T lymphocyte-expressing natural killer (NK) cell markers (NKT cells) play a role in immune regulation. Our aim was to evaluate the in vivo effect of adoptive transfer of immune-programmed NKT cells. Colitis was induced in C57/B6 mice by 2,4,6-trinitrobenzenesulfonic acid. NKT, CD4, CD8 lymphocytes, and dendritic cells (DC) were prepared from spleens of naive mice, animals with colitis, and animals with colitis that were orally tolerized. Subsets of splenocytes, NKT, CD4, and CD8 and NKT+CD4, NKT+CD8, and NKT+DC lymphocytes were prepared. Assessment of the T helper cell type 1 (Th1)/Th2 cytokine secretion paradigm in vitro was performed before and following exposure to the antigen. Adoptive transfer of ex vivo immune-programmed lymphocytes from each group was performed into recipient mice, followed by colitis induction. Ex vivo exposure of NKT cells harvested from mice with colitis-to-colitis proteins [colitis-extracted proteins (CEP)] led to a Th2 cytokine shift. The interleukin (IL)-4/interferon-γ (IFN-γ) ratio increased for NKT harvested from colitis-harboring mice following exposure to CEP. Adoptive transfer of NKT lymphocytes harvested from colitis-harboring mice, which were ex vivo-educated, significantly alleviated experimental colitis in vivo. Intrahepatic NKT lymphocytes increased significantly in mice transplanted with NKT lymphocytes harvested from colitis-harboring donor mice, which were ex vivo-exposed to CEP, similar to mice transplanted with NKT lymphocytes harvested from tolerized donors. Exposure of NKT cells to the disease-target antigen induced a significant increase in the IL-4/IFN-γ cytokine ratio. Adoptive transfer of a relatively small number of immune-programmed NKT cells induced a systemic Th1 to Th2-immune shift and alleviated immune-mediated colitis.Keywords
Funding Information
- Israel Science Foundation
- Roaman-Epstein Liver Research Foundation
- ENZO Biochem Inc.
This publication has 46 references indexed in Scilit:
- Natural Killer T Cell Ligand α-Galactosylceramide Enhances Protective Immunity Induced by Malaria VaccinesJournal of Experimental Medicine, 2002
- Immunomodulation of experimental colitis: the role of NK1.1 liver lymphocytes and surrogate antigens – bystander effectThe Journal of Pathology, 2001
- The role of NK1.1+ liver associated lymphocytes in peripheral immunemodulation of experimental colitis via oral tolerance or diet restrictionGastroenterology, 2001
- The role of NK1.1+ liver associated lymphocytes in peripheral immunemodulation of experimental colitis via oral tolerance or diet restrictionGastroenterology, 2001
- Natural T cells in the human liver: cytotoxic lymphocytes with dual T cell and natural killer cell phenotype and function are phenotypically heterogenous and include Vα24-JαQ and γδ T cell receptor bearing cellsHuman Immunology, 1999
- Oral tolerization to adenoviral proteins permits repeated adenovirus-mediated gene therapy in rats with pre-existing immunity to adenovirusesHepatology, 1998
- Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammationImmunology Today, 1997
- Long Term Correction of Bilirubin-UDP-glucuronosyltransferase Deficiency in Gunn Rats by Administration of a Recombinant Adenovirus during the Neonatal PeriodJournal of Biological Chemistry, 1996
- Cytokine imbalance and autoantibody production in T cell receptor-alpha mutant mice with inflammatory bowel disease.Journal of Experimental Medicine, 1996
- Mouse NK1.1+ T cells: a new family of T cellsImmunology Today, 1996